Cast nephropathy with acute renal failure treated with high cut-off haemodialysis in a patient with multiple myeloma

Hong Kong Medical Journal

Volumn 16, Issue 6, 2010, Pages 489-492

  Shum, H P ^a   Chan, K C ^a   Chow, C C ^a   Kho, Bonnie C S ^a   Yan, W W ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Acute; Kidney failure; Multiple myeloma; Plasma exchange; Renal dialysis

Indexed keywords

BENCE JONES PROTEIN; BETA 2 MICROGLOBULIN; BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN LAMBDA CHAIN; THALIDOMIDE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CAST NEPHROPATHY; CHINESE; FEMALE; HEMODIALYSIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; KIDNEY DISEASE; MULTIPLE MYELOMA; NORMOCHROMIC NORMOCYTIC ANEMIA; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; TREATMENT RESPONSE;

ACUTE KIDNEY INJURY; AGED; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; KIDNEY; MULTIPLE MYELOMA; RENAL DIALYSIS;

EID: 79951475187     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003;78:21-33.
2. Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol 2000;65:175-81.
3. Gertz MA. Managing myeloma kidney. Ann Intern Med 2005;143:835-7.
4. Montseny JJ, Kleinknecht D, Meyrier A, et al. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant 1998;13:1438-45.
5. Sanders PW, Booker BB. Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest 1992;89:630-9.
6. Leung N, Gertz MA, Zeldenrust SR, et al. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int 2008;73:1282-8.
7. Johnson WJ, Kyle RA, Pineda AA, O'Brien PC, Holley KE. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 1990;150:863-9.
8. Clark WF, Stewart AK, Rock GA, et al. Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med 2005;143:777-84.
9. Hutchison CA, Cockwell P, Reid S, et al. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol 2007;18:886-95.
10. Basnayake K, Hutchison C, Kamel D, et al. Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report. J Med Case Reports 2008;2:380.
11. Hutchison CA, Harding S, Mead G, et al. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care. Artif Organs 2008;32:910-7.
12. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D. Renal filtration, transport, and metabolism of low-molecularweight proteins: a review. Kidney Int 1979;16:251-70.
13. Waldmann TA, Strober W, Mogielnicki RP. The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia. J Clin Invest 1972;51:2162-74.
14. Cserti C, Haspel R, Stowell C, Dzik W. Light-chain removal by plasmapheresis in myeloma-associated renal failure. Transfusion 2007;47:511-4.
15. Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR. Serum free light chains for monitoring multiple myeloma. Br J Haematol 2004;126:348-54.